A genotype-phenotype taxonomy of hypertrophic cardiomyopathy

Lara Curran, Antonio de Marvao, Paolo Inglese, Kathryn A. McGurk, Pierre-Raphaël Schiratti, Adam Clement, Sean L. Zheng, Surui Li, Chee Jian Pua, Mit Shah, Mina Jafari, Pantazis Theotokis, Rachel Buchan, Sean J. Jurgens, Claire E. Raphael, A. John Baksi, Antonios Pantazis, Brian P. Halliday, Dudley J. Pennell, Wenjia Bai, Calvin Chin, Rafik Tadros, Connie R. Bezzina, Hugh Watkins, Stuart A. Cook, Sanjay Prasad, James S. Ware, Declan P. O’Regan

Abstract

Hypertrophic cardiomyopathy (HCM) is characterized by significant phenotypic heterogeneity, complicating risk assessment and clinical management. This study introduces a data-driven taxonomy of HCM by analyzing the three-dimensional (3D) structure of the left ventricle using machine learning. By mapping the relationship between cardiac morphology, genetic variants, and clinical outcomes, the researchers identified four distinct phenotypic branches. The findings reveal that pathogenic variants are associated with specific structural patterns and a significantly higher mortality risk, providing a framework for more personalized approaches to HCM.

Introduction

Hypertrophic cardiomyopathy (HCM) is a primary myocardial disorder and a significant cause of sudden cardiac death and heart failure. Despite its clinical importance, HCM is notoriously heterogeneous; patients exhibit a wide range of heart wall thickening patterns, genetic backgrounds, and clinical trajectories. Traditional classification systems rely on subjective visual assessments of two-dimensional images, often categorizing morphology into broad types like "sigmoid" or "reverse curve." However, these labels frequently fail to reflect the underlying genetic drivers or predict long-term outcomes accurately.

To address this, a recent study utilized machine learning to develop a systematic, 3D taxonomy of HCM. By integrating high-resolution imaging with genetic data, the researchers aimed to bridge the gap between a patient's physical heart structure (phenotype) and their genetic risk (genotype).

Methodology

The study analyzed a discovery cohort of 436 HCM patients from the NIHR Royal Brompton Hospital Cardiovascular Biobank, a validation cohort of 60 patients from Singapore, and a reference population of 16,691 individuals from the UK Biobank.

The researchers employed a multi-step computational pipeline:

  1. 3D Cardiac Modeling: Deep learning was used to segment Cardiac Magnetic Resonance (CMR) images, creating high-resolution 3D models of the left ventricle.
  2. Unsupervised Learning: A technique called Discriminative Dimensionality Reduction via Learning a Tree (DDRTree) was applied to project these complex 3D shapes into a 2D "phenotypic tree." This approach allows for the visualization of how different heart shapes transition along a continuum.
  3. Genomic Integration: Patients were stratified based on the presence of rare pathogenic or likely pathogenic (P/LP) variants. Additionally, Polygenic Risk Scores (PGS) were calculated to assess the impact of common genetic variations.
  4. Survival Analysis: Mortality data were projected onto the phenotypic tree to identify high-risk structural patterns.

A New Taxonomy of HCM

The unsupervised model identified four primary branches of disease expression, representing distinct structural trajectories:

  1. Non-sarcomeric Hypertrophy: Characterized by thickening in the mid-to-apical regions, often associated with co-existing hypertension.
  2. Diffuse and Basal Asymmetric Hypertrophy: Associated with left ventricular outflow tract obstruction (LVOTO).
  3. Isolated Basal Hypertrophy: A milder form of thickening, potentially related to aging.
  4. Milder Non-obstructive Hypertrophy: This branch was highly enriched for familial sarcomeric HCM, showing a strong association with high-risk genetic mutations.

Key Findings

The Genotype-Phenotype Paradox

One of the study's most striking findings was that carriers of P/LP variants (SARC-P/LP) actually exhibited lower overall left ventricular mass compared to genotype-negative individuals. However, their hypertrophy was more localized, specifically targeting the basal septum. This suggests that the pattern of remodeling, rather than the total amount of thickened muscle, is a more critical indicator of genetic risk.

Mortality and Genetic Risk

The clinical implications of this taxonomy are significant. Patients carrying P/LP variants had a 2.66-fold higher risk of death compared to genotype-negative patients. The median lifespan for these genetic carriers was 67 years, compared to 76 years for those without such variants. Branch 4 of the phenotypic tree was identified as the most "genetic" cluster, with an odds ratio of 2.18 for carrying a pathogenic variant.

Generalizability and Polygenic Influence

The model's robustness was confirmed using the Singaporean cohort, where it achieved a trustworthiness score of 0.86–0.88. This indicates that the 3D structural patterns of HCM are consistent across different ancestries. Furthermore, the study highlighted that even in the absence of a single rare mutation, common genetic variations (polygenic risk) significantly influence the severity and shape of cardiac remodeling.

Conclusion

This research moves HCM classification from subjective categories toward a continuous, data-driven framework. By mapping the 3D structure of the heart onto a phenotypic tree, clinicians can better understand the relationship between morphology, genetics, and prognosis. This taxonomy provides a foundation for future "multi-omic" integration and the development of clinical tools that can provide personalized risk profiles based on standard cardiac imaging.

Summary updated

Abstract

Abstract Background Hypertrophic cardiomyopathy (HCM) is an important cause of sudden cardiac death associated with heterogeneous phenotypes but there is no systematic framework for classifying morphology or assessing associated risks. Here we quantitatively survey genotype-phenotype associations in HCM to derive a data-driven taxonomy of disease expression. Methods We enrolled 436 HCM patients (median age 60 years; 28.8% women) with clinical, genetic and imaging data. An independent cohort of 60 HCM patients from Singapore (median age 59 years; 11% women) and a reference population from UK Biobank (n = 16,691, mean age 55 years; 52.5% women) were also recruited. We used machine learning to analyse the three-dimensional structure of the left ventricle from cardiac magnetic resonance imaging and build a tree-based classification of HCM phenotypes. Genotype and mortality risk distributions were projected on the tree. Results Carriers of pathogenic or likely pathogenic variants for HCM (P/LP) variants had lower left ventricular mass, but greater basal septal hypertrophy, with reduced lifespan (mean follow-up 9.9 years) compared to genotype negative individuals (hazard ratio: 2.66; 95% confidence interval [CI]: 1.42-4.96; P < 0.002). Four main phenotypic branches were identified using unsupervised learning of three-dimensional shape: 1) non-sarcomeric hypertrophy with co-existing hypertension; 2) diffuse and basal asymmetric hypertrophy associated with outflow tract obstruction; 3) isolated basal hypertrophy; 4) milder non-obstructive hypertrophy enriched for familial sarcomeric HCM (odds ratio for P/LP variants: 2.18 [95% CI: 1.93-2.28, P = 0.0001]). Polygenic risk for HCM was also associated with different patterns and degrees of disease expression. The model was generalisable to an independent cohort (trustworthiness M 1 : 0.86-0.88). Conclusions We report a data-driven taxonomy of HCM for identifying groups of patients with similar morphology while preserving a continuum of disease severity, genetic risk and outcomes. This approach will be of value in understanding the causes and consequences of disease diversity.
BibTeX
@article{curran2024genotype,
  author = {Lara Curran and Antonio de Marvao and Paolo Inglese and Kathryn A. McGurk and Pierre-Raphaël Schiratti and Adam Clement and Sean L. Zheng and Surui Li and Chee Jian Pua and Mit Shah and Mina Jafari and Pantazis Theotokis and Rachel Buchan and Sean J. Jurgens and Claire E. Raphael and A. John Baksi and Antonios Pantazis and Brian P. Halliday and Dudley J. Pennell and Wenjia Bai and Calvin Chin and Rafik Tadros and Connie R. Bezzina and Hugh Watkins and Stuart A. Cook and Sanjay Prasad and James S. Ware and Declan P. O’Regan},
  title = {{A genotype-phenotype taxonomy of hypertrophic cardiomyopathy}},
  journal = {Journal of Cardiovascular Magnetic Resonance},
  year = {2024},
  doi = {10.1016/j.jocmr.2024.100168},
}
Figure